Search Results

No progression of subclinical atherosclerosis in HIV-infected patients starting an initial regimen including tenofovir alafenamide/emtricitabine plus raltegravir, dolutegravir or elvitegravir/cobicistat during a two-year follow-up.

• Authors : Calza, Leonardo (AUTHOR); Borderi, Marco (AUTHOR); Colangeli, Vincenzo (AUTHOR)

Subjects: CAROTID intima-media thickness; DOPPLER ultrasonography; ANTIRETROVIRAL agents

• Source: Infectious Diseases. Apr2020, Vol. 52 Issue 4, p249-256. 8p. 1 Diagram, 2 Charts.

Record details

Increased CD4/CD8 ratio as a risk factor for critical illness in coronavirus disease 2019 (COVID-19): a retrospective multicentre study.

• Authors : Pallotto, Carlo^1,2 (AUTHOR) ; Suardi, Lorenzo Roberto¹ (AUTHOR); Esperti, Sara¹ (AUTHOR)

Subjects: *COVID-19; *CRITICALLY ill; *OXYGEN in the blood

• Source: Infectious Diseases. Sep2020, Vol. 52 Issue 9, p675-677. 3p. 1 Chart, 1 Graph.

Record details

Rosuvastatin decreases serum inflammatory markers and slows atherosclerosis progression rate in treated HIV-infected patients with metabolic syndrome.

• Authors : Calza, Leonardo (AUTHOR); Colangeli, Vincenzo (AUTHOR); Borderi, Marco (AUTHOR)

Subjects: CAROTID intima-media thickness; ATHEROSCLEROSIS; BIOMARKERS

• Source: Infectious Diseases. Feb2021, Vol. 53 Issue 2, p81-88. 8p. 3 Charts.

Record details

In-flight transmission cluster of COVID-19: a retrospective case series.

• Authors : Yang, Naibin (AUTHOR); Shen, Yuefei (AUTHOR); Shi, Chunwei (AUTHOR)

Subjects: COVID-19; INCUBATION period (Communicable diseases); INTENSIVE care units

• Source: Infectious Diseases. Nov2020, Vol. 52 Issue 12, p891-901. 11p. 1 Color Photograph, 1 Diagram, 4 Charts.

Record details

Antiretroviral treatment for HIV infection: Swedish recommendations 2019.

• Authors : Eriksen, Jaran (AUTHOR); Carlander, Christina (AUTHOR); Albert, Jan (AUTHOR)

Subjects: HIV infections; HIV infection transmission; EVIDENCE-based medicineSWEDEN

• Source: Infectious Diseases. May2020, Vol. 52 Issue 5, p295-329. 35p. 5 Charts.

Record details

Lack of impact of protease inhibitor resistance-associated mutations on the outcome of HIV-1-infected patients switching to darunavir-based dual therapy.

• Authors : Vizcarra, Pilar (AUTHOR); Blanco, José L. (AUTHOR); Montejano, Rocío (AUTHOR)

Subjects: NON-nucleoside reverse transcriptase inhibitors; PROTEASE inhibitors; NUCLEOSIDE reverse transcriptase inhibitors

• Source: Infectious Diseases. Mar2020, Vol. 52 Issue 3, p202-206. 5p. 2 Charts.

Record details

Dolutegravir monotherapy: an option for highly adherent HIV1-infected naive patients with relatively low zenith HIV-RNA?

• Authors : Lanzafame, Massimiliano¹ ; Rizzardo, Sebastiano²; Piacentini, Daniela²

• Source: Infectious Diseases. Jan2019, Vol. 51 Issue 1, p77-78. 2p.

Record details

Switching from a regimen containing abacavir/lamivudine or emtricitabine/tenofovir disoproxil fumarate to emtricitabine/tenofovir alafenamide fumarate does not affect central nervous system HIV-1 infection.

• Authors : Yilmaz, Aylin (AUTHOR); Mellgren, Åsa (AUTHOR); Fuchs, Dietmar (AUTHOR)

Subjects: CENTRAL nervous system infections; CENTRAL nervous system; HIV infections

• Source: Infectious Diseases. Nov/Dec2019, Vol. 51 Issue 11/12, p838-846. 9p. 1 Chart, 3 Graphs.

Record details

Management of hepatitis B virus infection, updated Swedish guidelines.

• Authors : Westin, Johan; Aleman, Soo; Castedal, Maria

Subjects: HEPATITIS B virus; VIRUS diseases; LIVER cancer

• Source: Infectious Diseases. Jan2020, Vol. 52 Issue 1, p1-22. 22p.

Record details

Is HIV-1 viraemia below 20 copies/mL in antiretroviral-treated patients associated with virologic outcome?

• Authors : den Oudsten, Myriam; van Kampen, Jeroen; Rijnders, Bart

Subjects: VIREMIA; LOGISTIC regression analysis; REGRESSION analysis

• Source: Infectious Diseases. Apr2019, Vol. 51 Issue 4, p259-267. 9p. 2 Diagrams, 3 Charts.

Record details